Exact Mass: 645.1878102000001

Exact Mass Matches: 645.1878102000001

Found 30 metabolites which its exact mass value is equals to given mass value 645.1878102000001, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cefoperazone

(6R,7R)-7-[(2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)(hydroxy)methylidene]amino}-1-hydroxy-2-(4-hydroxyphenyl)ethylidene)amino]-3-{[(1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulphanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C25H27N9O8S2 (645.1423942000001)


Cefoperazone is only found in individuals that have used or taken this drug. It is a semisynthetic broad-spectrum cephalosporin with a tetrazolyl moiety that is resistant to beta-lactamase. It has been proposed especially against Pseudomonas infections.Like all beta-lactam antibiotics, cefoperazone binds to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, causing the inhibition of the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DD - Third-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

DPDPE

DPDPE

C30H39N5O7S2 (645.2290784)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D018377 - Neurotransmitter Agents > D018847 - Opioid Peptides D018377 - Neurotransmitter Agents > D004745 - Enkephalins DPDPE, an opioid peptide, is a selective δ-opioid receptor?(DOR) agonist?with anticonvulsant effects[1]. DPDPE, an opioid peptide, is a selective δ-opioid receptor?(DOR) agonist?with anticonvulsant effects[1].

   

Netarsudil Mesylate

Netarsudil Mesylate

C30H35N3O9S2 (645.1814620000001)


C78283 - Agent Affecting Organs of Special Senses > C29705 - Anti-glaucoma Agent

   

Ustiloxin B

2-amino-5-{[(5Z,8E)-4-[(Z)-(carboxymethyl)-C-hydroxycarbonimidoyl]-3-ethyl-6,9,11,15-tetrahydroxy-3,7-dimethyl-10-(methylamino)-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(16),5,8,12,14-pentaen-13-yl]sulfinyl}-4-hydroxypentanoic acid

C26H39N5O12S (645.2315814000001)


Ustiloxin B is found in cereals and cereal products. Ustiloxin B is isolated from the false smut balls caused by Ustilaginoidea virens on rice. Isolated from the false smut balls caused by Ustilaginoidea virens on rice. Ustiloxin B is found in cereals and cereal products.

   

(D-Pen2,D-Pen5)-Enkephalin

13-{[2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-7-benzyl-6,9,12-trihydroxy-3,3,14,14-tetramethyl-1,2-dithia-5,8,11-triazacyclotetradeca-5,8,11-triene-4-carboxylate

C30H39N5O7S2 (645.2290784)


   

ZORUBICIN

N-(1-{4-[(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy]-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl}ethylidene)benzenecarbohydrazonate

C34H35N3O10 (645.2322330000001)


   

3-Piperidinecarboxamide, N-((2-chloro-5-(2-methoxyethyl)phenyl)methyl)-N-cyclopropyl-4-(6-(2-(2,6-dichloro-4-methylphenoxy)ethoxy)-3-pyridinyl)-, (3R,4S)-

3-Piperidinecarboxamide, N-((2-chloro-5-(2-methoxyethyl)phenyl)methyl)-N-cyclopropyl-4-(6-(2-(2,6-dichloro-4-methylphenoxy)ethoxy)-3-pyridinyl)-, (3R,4S)-

C33H38Cl3N3O4 (645.1927758)


   

Cefoperazone

Cefoperazone (Cefobid)

C25H27N9O8S2 (645.1423942000001)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DD - Third-generation cephalosporins A semi-synthetic parenteral cephalosporin with a tetrazolyl moiety that confers beta-lactamase resistance. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic CONFIDENCE standard compound; INTERNAL_ID 1050

   

3-Deoxystreptomycin 6-phosphate

3-Deoxystreptomycin 6-phosphate

C21H40N7O14P (645.237075)


   

3-Deoxystreptomycin 3-phosphate

3-Deoxystreptomycin 3-phosphate

C21H40N7O14P (645.237075)


   

Ustiloxin B

2-amino-5-{4-[(carboxymethyl)carbamoyl]-3-ethyl-11,15-dihydroxy-3,7-dimethyl-10-(methylamino)-6,9-dioxo-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(16),12,14-triene-13-sulfinyl}-4-hydroxypentanoic acid

C26H39N5O12S (645.2315814000001)


A heterodetic cyclic peptide with formula C26H39N5O12S produced by Ustilaginoidea virens fungi. It is an inhibitor of microtubule assembly.

   

2-(4-N-BOC-AMINOBENZYL)-2,5-DIAZABICYCLO[2.2.1]HEPTANE

2-(4-N-BOC-AMINOBENZYL)-2,5-DIAZABICYCLO[2.2.1]HEPTANE

C23H28F9N3O8 (645.1732596)


   

chloro[(1,2,3-η)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)-4,5-dihydroimidazol-2-ylidene]palladium(ii)

chloro[(1,2,3-η)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)-4,5-dihydroimidazol-2-ylidene]palladium(ii)

C36H44ClN2Pd (645.2227584)


   

Holmium tris(1,1,1,3,3,3-hexamethyldisilazan-2-ide)

Holmium tris(1,1,1,3,3,3-hexamethyldisilazan-2-ide)

C18H54HoN3Si6 (645.2236504)


   
   

3-Oxazolidinecarboxylic acid, 4-[[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]methyl]-5-hydroxy-2,4-diphenyl-, phenylmethyl ester, (2R,4S)-

3-Oxazolidinecarboxylic acid, 4-[[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]methyl]-5-hydroxy-2,4-diphenyl-, phenylmethyl ester, (2R,4S)-

C34H29F6NO5 (645.1949815999999)


   
   

Rubidazon

N-[(E)-1-[(2S,4S)-4-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethylideneamino]benzamide

C34H35N3O10 (645.2322330000001)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DB - Anthracyclines and related substances C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents

   
   

(6R,7R)-7-[[(2S)-2-[[(4-Ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7R)-7-[[(2S)-2-[[(4-Ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C25H27N9O8S2 (645.1423942000001)


   

3-[N-[Benzyloxycarbonyl]-phenylalaninyl-amino]-5-phenyl-pentane-1-sulfonic acid 4-nitro-phenyl ester

3-[N-[Benzyloxycarbonyl]-phenylalaninyl-amino]-5-phenyl-pentane-1-sulfonic acid 4-nitro-phenyl ester

C34H35N3O8S (645.2144750000001)


   

4-deoxy-alpha-L-threo-hex-4-enopyranuronosyl-(1->4)-beta-D-glucopyranosyl-(1->4)-alpha-L-rhamnopyranosyl-(1->3)-D-glucopyranose

4-deoxy-alpha-L-threo-hex-4-enopyranuronosyl-(1->4)-beta-D-glucopyranosyl-(1->4)-alpha-L-rhamnopyranosyl-(1->3)-D-glucopyranose

C24H37O20- (645.1878102000001)


   

beta-D-Delta(4)-GlcpA-(1->4)-beta-D-Glcp-(1->4)-alpha-L-Rhap-(1->3)-beta-D-Glcp(1-)

beta-D-Delta(4)-GlcpA-(1->4)-beta-D-Glcp-(1->4)-alpha-L-Rhap-(1->3)-beta-D-Glcp(1-)

C24H37O20- (645.1878102000001)


   

(3S)-3-{[3,4-difluoro-5-({4-fluoro-6-[(3S)-pyrrolidinium-3-yloxy][biphenyl]-3-yl}carbamoyl)[biphenyl]-2-yl]oxy}pyrrolidinium dichloride

(3S)-3-{[3,4-difluoro-5-({4-fluoro-6-[(3S)-pyrrolidinium-3-yloxy][biphenyl]-3-yl}carbamoyl)[biphenyl]-2-yl]oxy}pyrrolidinium dichloride

C33H32Cl2F3N3O3 (645.1772698)


   

(6R,7R)-7-[[2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7R)-7-[[2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C25H27N9O8S2 (645.1423942000001)


   
   

(2s,4s)-2-amino-5-[(s)-(3s,4s,7r,10s,11r)-4-(carboxymethyl-c-hydroxycarbonimidoyl)-3-ethyl-6,9,11,15-tetrahydroxy-3,7-dimethyl-10-(methylamino)-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(16),5,8,12,14-pentaen-13-ylsulfinyl]-4-hydroxypentanoic acid

(2s,4s)-2-amino-5-[(s)-(3s,4s,7r,10s,11r)-4-(carboxymethyl-c-hydroxycarbonimidoyl)-3-ethyl-6,9,11,15-tetrahydroxy-3,7-dimethyl-10-(methylamino)-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(16),5,8,12,14-pentaen-13-ylsulfinyl]-4-hydroxypentanoic acid

C26H39N5O12S (645.2315814000001)


   

(2s,4s)-2-amino-5-[(r)-(3r,4s,7s,10s,11r)-4-(carboxymethyl-c-hydroxycarbonimidoyl)-3-ethyl-6,9,11,15-tetrahydroxy-3,7-dimethyl-10-(methylamino)-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(16),5,8,12,14-pentaen-13-ylsulfinyl]-4-hydroxypentanoic acid

(2s,4s)-2-amino-5-[(r)-(3r,4s,7s,10s,11r)-4-(carboxymethyl-c-hydroxycarbonimidoyl)-3-ethyl-6,9,11,15-tetrahydroxy-3,7-dimethyl-10-(methylamino)-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(16),5,8,12,14-pentaen-13-ylsulfinyl]-4-hydroxypentanoic acid

C26H39N5O12S (645.2315814000001)


   

2-amino-5-[4-(carboxymethyl-c-hydroxycarbonimidoyl)-3-ethyl-6,9,11,15-tetrahydroxy-3,7-dimethyl-10-(methylamino)-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(16),5,8,12,14-pentaen-13-ylsulfinyl]-4-hydroxypentanoic acid

2-amino-5-[4-(carboxymethyl-c-hydroxycarbonimidoyl)-3-ethyl-6,9,11,15-tetrahydroxy-3,7-dimethyl-10-(methylamino)-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(16),5,8,12,14-pentaen-13-ylsulfinyl]-4-hydroxypentanoic acid

C26H39N5O12S (645.2315814000001)